Delivery Order SPE2DR25D1052-SPE2DR26F6BW3
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,385.52 for ORGOVYX 120 mg tablets (30-unit package) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.06 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on October 17, 2025, with completion targeted for November 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's existing pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,460.13 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-unit package) on October 22, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) with a firm fixed price arrangement. The contract, awarded on August 27, 2025, is classified as a non-set-aside competitive award with an ultimate completion date of September 18, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-unit package) with a firm fixed price and September 29, 2025 completion date. This is a non-set-aside, competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on October 20, 2025, for ORGOVYX 120 mg tablets in quantities of 30 units. The contract is valued at $1,460.13 with a firm fixed price structure and an ultimate completion date of November 10, 2025. This delivery order was issued under no set-aside provision, demonstrating the contractor's ability to compete in open federal procurement....
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) with a completion date of September 29, 2025. This non-set-aside contract was competitively awarded on September 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor serving federal medical procurement needs, particularly for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for ORGOVYX 120 mg tablets in quantities of 30 units, with a contract ceiling value of $2,771.04 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-unit package) on June 26, 2025, with completion scheduled for July 18, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical procurement supporting federal healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 11, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a contract ceiling value of $2,771.04. The award represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025. This contract was competitively awarded without set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain, a...
- SPE2DR25D1052Indefinite Delivery Contract
- SPE2DR25D1052-SPE2DR26F6BW3Delivery Order
The Defense Logistics Agency awarded a $1,460.13 delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on October 30, 2025, with completion scheduled for November 21, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, supporting the company's role as a primary pharmaceutical distributor for federal military and healthcare systems. This award is a child contract under AmerisourceBergen's broader $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen's substantial IDC enables the company to supply a comprehensive range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen maintains a significant portfolio of federal contracts with DLA, positioning the company as a critical vendor for military medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/30/25 |